Shenji Bio
About:
Shenji Bio focuses on the research and development of raw materials such as nucleosides, nucleotides, diagnostic antigens, and antibodies.
Website: http://www.syngenebio.com
Top Investors: LYFE Capital, Lake Bleu Capital, Sherpa Healthcare Partners, Lenovo Star
Description:
Shenji Bio focuses on the research and development of fundamental raw materials such as nucleosides, nucleotides, diagnostic antigens, and antibodies. As a development direction, Shenji Bio provides cost-effective products and addresses clinical unmet needs. It has gradually entered the upstream core raw material fields of IVD, mRNA, CGT, and other industries, and has established a high-quality key common technology platform to provide overall solutions for the life science field's development.
300M CNY
Nanjing, Jiangsu, China
2018-07-01
hr(AT)syngenebio.com
51-100
2022-04-11
Private
© 2025 bioDAO.ai